- Home
- SAR vs ETON Comparison
SAR vs ETON Comparison
Compare SAR & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAR
- ETON
- Stock Information
- Founded
- SAR 2007
- ETON 2017
- Country
- SAR United States
- ETON United States
- Employees
- SAR N/A
- ETON N/A
- Industry
- SAR Investment Managers
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- SAR Finance
- ETON Health Care
- Exchange
- SAR Nasdaq
- ETON Nasdaq
- Market Cap
- SAR 309.4M
- ETON 329.8M
- IPO Year
- SAR 2007
- ETON 2018
- Fundamental
- Price
- SAR $23.49
- ETON $14.34
- Analyst Decision
- SAR Buy
- ETON Strong Buy
- Analyst Count
- SAR 4
- ETON 3
- Target Price
- SAR $25.08
- ETON $27.67
- AVG Volume (30 Days)
- SAR 99.2K
- ETON 239.3K
- Earning Date
- SAR 05-07-2025
- ETON 05-08-2025
- Dividend Yield
- SAR 14.15%
- ETON N/A
- EPS Growth
- SAR 33.28
- ETON N/A
- EPS
- SAR 2.49
- ETON N/A
- Revenue
- SAR $154,793,533.00
- ETON $39,011,000.00
- Revenue This Year
- SAR $6.07
- ETON $92.33
- Revenue Next Year
- SAR N/A
- ETON $52.62
- P/E Ratio
- SAR $9.45
- ETON N/A
- Revenue Growth
- SAR 11.52
- ETON 23.29
- 52 Week Low
- SAR $21.10
- ETON $3.03
- 52 Week High
- SAR $26.49
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- SAR 47.54
- ETON 55.85
- Support Level
- SAR $22.60
- ETON $11.09
- Resistance Level
- SAR $23.24
- ETON $14.40
- Average True Range (ATR)
- SAR 0.92
- ETON 0.99
- MACD
- SAR -0.04
- ETON 0.29
- Stochastic Oscillator
- SAR 53.35
- ETON 95.31
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.